Search results
Top Advisors Pledge $500,000 To Fund Breast Cancer Drug Therapy
Forbes· 3 days agoTop Forbes | SHOOK financial advisors and Wall Street investment firms have pledged more than...
Sana Al Sukhun, MD, on Metastatic Breast Cancer Treatment in Lower-Income Settings
MedPage Today· 6 days agoTreatment guidelines for patients with metastatic breast cancer often recommend tests, drugs, and...
Red Flags for Early-Onset Colorectal Cancer Identified
Medscape· 6 days agoThe most common presenting signs and symptoms of early-onset colorectal cancer include rectal...
Midland Park annual color run raised $100,000 for metastatic breast cancer research
Gannett via AOL· 2 days agoMIDLAND PARK — The third annual Color Fun Run attracted 700 runners to the DePhillips Dairy Barn who...
Valuable Guidelines on Prescribing for Patients With Metastatic Breast Cancer in Resource-Scarce...
MedPage Today· 6 days agoStandard-of-care guidelines differ widely from countries with historic access to medical innovation...
ASCO24: Can Ambrx’s novel ADC break into the metastatic breast cancer market?
Pharmaceutical Technology via Yahoo Finance· 6 days agoARX788 is attempting to enter a crowded field, Enhertu (trastuzumab deruxtecan) is the standard of...
Tip Sheet: Breast cancer guidelines change again, | Newswise
Newswise· 5 days agoBelow are summaries of recent Fred Hutchinson Cancer Center research findings and other news. March is Colorectal Cancer Awareness Month, contact our media
Women denied ‘wonder drug’ that could double terminal breast cancer life expectancy
Daily Telegraph· 7 days agoWomen with HER2-low or ultra-low breast cancer who took Enhertu lived without their cancer growing...
Advancements in metastatic cancer treatments offer new hope to patients
WTVD-TV 11 Raleigh-Durham· 5 days agoPam Kohl remembers being told of her stage four metastatic breast cancer diagnosis. "I'm in treatment, (and) will be in treatment forever ...
Relay Therapeutics to Collaborate with Pfizer to Evaluate Breast Cancer Treatment
Morningstar· 4 days agoRelay Therapeutics will collaborate with Pfizer to study atirmociclib in combination with RLY-2608 and fulvestrant in patients with certain types of metastatic breast ...